|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 3.32B 2.89B 2.67B 2.51B 4.69B 313B 4.73B 31.74B 12.33B 154B 12.47B 12.2B 535B | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3.03B 2.79B 2.63B 4.91B 328B 4.95B 33.23B 12.9B 162B 13.05B 12.77B 560B | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/09/25 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 29/07/25 | Amedisys: Q2 Earnings Snapshot | AQ |
| 29/07/25 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 29/07/25 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 23/04/25 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 1 year | 95.55 |  | 101.02 |
| 3 years | 82.15 | | 101.02 |
| 5 years | 69.36 | | 276.21 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 05/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 31/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/08/25 | Issuer sale | Compliance Officer | 40,579 | 0.1239% | ||
| 13/08/25 | Issuer sale | Director | 23,992 | 0.0732% | ||
| 13/08/25 | Issuer sale | Controller/Auditor | 11,539 | 0.0352% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.24B 1.95B 1.8B 1.69B 3.16B 211B 3.18B 21.37B 8.3B 104B 8.39B 8.21B 360B | 2.35B 2.05B 1.89B 1.77B 3.32B 221B 3.34B 22.44B 8.71B 109B 8.81B 8.63B 378B |
| Net income | -9.75M -8.49M -7.83M -7.36M -13.78M -919M -13.87M -93.14M -36.17M -453M -36.59M -35.8M -1.57B | 43.23M 37.67M 34.72M 32.66M 61.1M 4.07B 61.53M 413M 160M 2.01B 162M 159M 6.96B |
| Net Debt | 361M 314M 290M 273M 510M 34B 513M 3.45B 1.34B 16.76B 1.35B 1.33B 58.08B | 156M 136M 125M 118M 221M 14.71B 222M 1.49B 579M 7.25B 586M 573M 25.12B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
